ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting

PURPOSE: The purpose of this study was to identify the excision repair cross-complementation group 1 (ERCC1) as a predictive marker for FOLFOX adjuvant chemotherapy in stages II and III colon cancer patients. METHODS: A total of 166 high risk stages II and III colon cancer patients were retrospectiv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Coloproctol
Main Authors: Kim, Chee Young, Seo, Sang Hyuk, An, Min Sung, Kim, Kwang Hee, Bae, Ki Beom, Hwang, Jin Won, Kim, Ji Hyun, Kim, Bo Mi, Kang, Mi Seon, Oh, Min Kyung, Hong, Kwan Hee
Format: Artigo
Sprog:Inglês
Udgivet: The Korean Society of Coloproctology 2015
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496459/
https://ncbi.nlm.nih.gov/pubmed/26161376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/ac.2015.31.3.92
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker